Clinical Trials Directory

Trials / Completed

CompletedNCT01063738

Rehabilitating Muscle After Intensive Care

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
93 (actual)
Sponsor
St Helens & Knowsley Teaching Hospitals NHS Trust · Academic / Other
Sex
All
Age
45 Years – 99 Years
Healthy volunteers
Not accepted

Summary

The study will examine the effect of amino acid supplements and enhanced physiotherapy on physical recovery following critical illness in intensive care.

Detailed description

Critically ill patients aged 45 years and over will be recruited during recovery after intensive care. Using a randomised controlled, blind at follow-up design the study will examine whether the combination of an amino acid supplement and an enhanced physiotherapy programme improve the rehabilitation of muscle following intensive care better than a self-guided rehabilitation programme alone or with either an amino acid supplement or the enhanced physiotherapy programme. The Primary efficacy outcome will be the improvement in six minute walking test measured at 3 months post intensive care discharge. Secondary efficacy parameters will be insulin resistance, health related quality of life and muscle mass using DEXA scanning at 3 months and 1 year post intensive care discharge.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTAmino acid supplementFlavoured essential amino acid supplement and glutamine dipeptide taken twice daily for 3 months
OTHERPEPSEEnhanced physiotherapy programme of 3 1 hour sessions per week for 6 weeks while in hospital and once discharged home 1 supervised outpatient session of 1 hour and 2 home exercise sessions per week (PEPSE).
OTHERIntensive Care Unit (ICU) Recovery ManualStandard self-directed 6 week rehabilitation package
DIETARY_SUPPLEMENTPlacebo nutritional supplementCherry flavoured low calorie and low protein placebo drink

Timeline

Start date
2010-08-01
Primary completion
2014-03-01
Completion
2014-11-01
First posted
2010-02-05
Last updated
2019-10-03

Locations

2 sites across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT01063738. Inclusion in this directory is not an endorsement.